Tilray Brands, Inc. Repayments of Long-Term Debt
Tilray Brands, Inc. (TLRY) reported Repayments of Long-Term Debt of $6.37 million for the 3-month period ending 2023-08-31, per its 10-Q filed 2024-10-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2024-10-10
- Tilray Brands, Inc. repayments of long-term debt for the quarter ending 2023-08-31 was $6.37M, a 22.58% increase year-over-year.
- Tilray Brands, Inc. repayments of long-term debt for the quarter ending 2023-02-28 was $5.26M, a 61.84% decline year-over-year.
- Tilray Brands, Inc. repayments of long-term debt for the quarter ending 2022-11-30 was $54.20M.
- Tilray Brands, Inc. repayments of long-term debt for the quarter ending 2022-08-31 was $5.20M.
- Tilray Brands, Inc. repayments of long-term debt for fiscal 2016 was $2.19M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-08-31 | $6.37M 10-Q · filed 2024-10-10 | |||
| 2023-02-28 | $5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $59.46M derived: sum of 2 quarters · filed 2023-04-10 | $64.66M 10-Q · filed 2023-04-10 | |
| 2022-11-30 | $54.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $59.40M 10-Q · filed 2023-01-09 | ||
| 2022-08-31 | $5.20M 10-Q · filed 2024-10-10 | |||
| 2022-02-28 | $13.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $34.57M 10-Q · filed 2023-04-10 | ||
| 2021-11-30 | $20.78M 10-Q · filed 2023-01-09 | |||
| 2016-12-31 | $2.19M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |